# BenevolentAI vs Connected Papers

BenevolentAI records 0 monthly visits with 0% month-over-month growth and Contact for Pricing pricing. Connected Papers records 750,576 monthly visits with +3.1% growth and Freemium pricing.

| Metric | [BenevolentAI](https://openaitools.app/tool/benevolent-ai) | [Connected Papers](https://openaitools.app/tool/connected-papers) |
| :--- | :--- | :--- |
| Website URL | https://benevolent.ai | https://www.connectedpapers.com |
| Categories | AI Healthcare, AI Research Tool, AI Knowledge Graph | AI Research Tool, AI Knowledge Graph, AI Search Engine, AI Research Papers |
| Pricing Model | Contact for Pricing | Freemium |
| Monthly Visits | 0 | 750,576 |
| MoM Growth Rate | 0% | +3.1% |
| Primary Market | Global | United States |
| Direct Visits | 0 | 308,439 |
| Review Score | 4.3 | 4.7 |
| Saved Count | 0 | 15 |
| Supported Platforms | Website | Website |

## BenevolentAI

BenevolentAI is a biopharma technology company that applies advanced artificial intelligence to the discovery of new medicines and to life science intelligence. Its foundation is a decade-long investment in a proprietary biomedical knowledge graph and set of ontologies, which give machine learning models a structured, curated view of scientific knowledge to reason over.

The company brings together science and technology teams who work with partners to embed AI into real drug-discovery workflows — from hypothesis generation and target identification to prioritising mechanisms worth pursuing. BenevolentAI also offers Qor, an always-on strategic function that helps biopharma decision makers and life science consultancies draw insight from scientific data.

BenevolentAI is headquartered in Luxembourg and listed on Euronext Amsterdam under the ticker BAI. Because its work is enterprise-focused, access and scope are arranged directly with the company rather than through self-serve plans.

**Pricing & Plans:** Contact for pricing. BenevolentAI does not publish public plans; access to its drug-discovery platform and the Qor intelligence offering is arranged directly with the company.

- **Biomedical knowledge graph:** A decade of investment in a proprietary biomedical knowledge graph and ontologies that structure scientific data for machine learning.
- **AI-driven drug discovery:** Apply AI and machine learning to identify and prioritise promising drug targets and mechanisms.
- **Qor life science intelligence:** An always-on strategic function that turns life science data into insight for biopharma decision makers and consultancies.
- **Science-first collaboration:** Teams of scientists and engineers work with partners to embed cutting-edge AI into real R&D workflows.

**Strengths:** Deep, longstanding investment in a curated biomedical knowledge graph and ontologies; Combines scientific and engineering expertise in one organisation; Applies AI to concrete drug-discovery and R&D decisions rather than generic tasks; Listed, established company with an enterprise track record in biopharma

**Limitations:** No self-serve sign-up or transparent pricing — engagement starts with a sales conversation; Deeply specialised for biopharma R&D, so it is not useful outside life sciences; Outputs are decision-support insights that still require expert scientific validation; Access and scope are shaped by enterprise partnership terms rather than open plans

[Profile (Markdown)](https://openaitools.app/tool/benevolent-ai.md)

## Connected Papers

The underlying problem Connected Papers tackles is that a literature review is usually conducted linearly: you find one paper, follow its citations, follow theirs, and gradually lose the thread of the wider field. Connected Papers instead computes similarity across a large scholarly corpus — building on data sources such as Semantic Scholar and Crossref — and lays the results out spatially. Papers that are frequently cited together or that share a large body of references cluster near each other, while the connecting edges show how strongly any two nodes relate. The layout is generated consistently, so the same graph is reproduced on later visits rather than reshuffling unpredictably.

The interface gives you two complementary views. The graph view is for orientation: which papers are central, which are recent, and which bridges connect separate clusters. The list view ranks related works by similarity and citation signals so you can drill into something specific. Common entry points include an arbitrary paper, a DOI, a URL, or a link to a conference proceedings. Prior Works and Derivative Works views are especially useful when you want to trace a field's ancestry or find what later built on a paper.

The service is aimed squarely at graduate students, postdocs and applied scientists who need to get up to speed on unfamiliar territory quickly — whether writing a related-work section, preparing a grant, or sanity-checking whether an idea has already been published. It is an independent research tool, not a publisher or a repository; the graphs are a discovery aid layered on top of existing scholarly metadata.

**Pricing & Plans:** Freemium

- **Similarity graph visualisation:** Each graph places the seed paper among its most closely related works, clustered by how often papers are cited together or share references.
- **Prior and derivative works views:** Separate perspectives show what a paper builds on and what later work builds on it, which is ideal for tracing a research lineage.
- **Multiple search inputs:** Start from a paper title, DOI, URL or proceedings link, so you can enter the graph from whatever you already have at hand.
- **Ranked list alongside the graph:** A ranked list view lets you browse related publications by relevance when you need specifics rather than an overview.
- **Stable, reproducible layouts:** The same graph is generated again on later visits, making it practical to bookmark a field's map and return to it while writing.

**Strengths:** Turns an otherwise linear citation chase into a spatial overview; Prior and derivative views make research lineage explicit; Works from a title, DOI or URL, so entry is frictionless; Free tier is enough to try it on real research tasks

**Limitations:** Requires JavaScript, so it cannot be read or scraped as a plain page; Graph quality depends on how well indexed the field is in the underlying corpus; Heaviest research-grade features sit behind paid plans

[Profile (Markdown)](https://openaitools.app/tool/connected-papers.md)

## Frequently Asked Questions

### How do BenevolentAI and Connected Papers compare in monthly traffic?

BenevolentAI has 0 monthly visits, while Connected Papers has 750,576. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

BenevolentAI has a month-over-month growth rate of 0%; Connected Papers has +3.1%.

### How does pricing compare?

BenevolentAI: Contact for Pricing. Contact for pricing. BenevolentAI does not publish public plans; access to its drug-discovery platform and the Qor intelligence offering is arranged directly with the company. Connected Papers: Freemium. Freemium

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Semantic Scholar](https://openaitools.app/tool/semantic-scholar) | 8,198,672 | +5.8% | Free | Provides broader citation data across millions of papers, but lacks Connected Papers' proprietary graphical relationship view. | [.md](https://openaitools.app/tool/semantic-scholar.md) |
| 2 | [Consensus](https://openaitools.app/tool/consensus) | 6,014,388 | -1.2% | Freemium | Focuses on answering specific research questions with extracted evidence, rather than exploring visual citation graphs. | [.md](https://openaitools.app/tool/consensus.md) |
| 3 | [SciSpace](https://openaitools.app/tool/scispace) | 4,464,111 | +8.6% | Freemium | Integrates deep PDF reading and analysis workspaces, but lacks dedicated visual citation network mapping capabilities. | [.md](https://openaitools.app/tool/scispace.md) |
| 4 | [Branded](https://openaitools.app/tool/gobranded-com) | 3,704,728 | +6.6% | Contact for Pricing | Targeted research audiences with AI-verified data quality | [.md](https://openaitools.app/tool/gobranded-com.md) |
| 5 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | Excels at automating systematic reviews and data extraction, but lacks interactive graphical citation tree exploration. | [.md](https://openaitools.app/tool/elicit.md) |
| 6 | [Scite](https://openaitools.app/tool/scite) | 841,974 | +1.1% | Free Trial, Contact for Pricing | Tracks citation reliability and context via Smart Citations, but offers less visual graph-based exploration of literature. | [.md](https://openaitools.app/tool/scite.md) |
| 7 | [ResearchRabbit](https://openaitools.app/tool/researchrabbit) | 831,571 | +3.1% | Free | Offers a similarly polished visual literature mapping interface, but adds collaborative collection management features. | [.md](https://openaitools.app/tool/researchrabbit.md) |
| 8 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 9 | [Paperguide](https://openaitools.app/tool/paperguide) | 371,972 | -2.9% | Freemium | Streamlines literature search and reference management, but does not provide an interactive visual citation graph. | [.md](https://openaitools.app/tool/paperguide.md) |
| 10 | [WisPaper](https://openaitools.app/tool/wispaper) | 107,817 | +0.1% | Freemium | Helps discover and track academic papers and trends, but offers less robust visual citation graph mapping. | [.md](https://openaitools.app/tool/wispaper.md) |

---
Source: https://openaitools.app/compare/benevolent-ai-vs-connected-papers

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
